Search Results - "Mitchell, S. A."

Refine Results
  1. 1

    Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis by Cohen, A T, Hamilton, M, Mitchell, S A, Phatak, H, Liu, X, Bird, A, Tushabe, D, Batson, S

    Published in PloS one (30-12-2015)
    “…Anticoagulation with low molecular weight heparin and vitamin K antagonists is the current standard of care (SOC) for venous thromboembolism (VTE) treatment…”
    Get full text
    Journal Article
  2. 2

    Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis by Cohen, A T, Hamilton, M, Bird, A, Mitchell, S A, Li, S, Horblyuk, R, Batson, S

    Published in PloS one (03-08-2016)
    “…Historically, warfarin or aspirin have been the recommended therapeutic options for the extended treatment (>3 months) of VTE. Data from Phase III randomised…”
    Get full text
    Journal Article
  3. 3

    Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall period by Lee, M. K., Basch, E., Mitchell, S. A., Minasian, L. M., Langlais, B. T., Thanarajasingam, G., Ginos, B. F., Rogak, L. J., Mendoza, T. R., Bennett, A. V., Schrag, D., Mazza, G. L., Dueck, A. C.

    Published in Quality of life research (01-07-2023)
    “…Purpose The standard recall period for the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®) is the past…”
    Get full text
    Journal Article
  4. 4

    Linguistic validation of the simplified Chinese version of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™) by Kkf, Cheng, Mitchell, S A, Chan, N, Ang, E, Tam, W, Kanesvaran, R

    Published in BMC cancer (26-11-2020)
    “…The aim of this study was to translate and linguistically validate the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common…”
    Get full text
    Journal Article
  5. 5

    Systematic review of the patient burden of generalised myasthenia gravis in Europe, the Middle East, and Africa by McCallion, J, Borsi, A, Noel, W, Lee, J, Karmous, W, Sattler, S, Boggia, G M, Hardy, E J, Mitchell, C R, Mitchell, S A, Gilhus, Nils Erik

    Published in BMC neurology (10-02-2024)
    “…Myasthenia gravis (MG) is a rare autoimmune disease characterised by muscle weakness, and progression from ocular (oMG) to generalised (gMG) symptoms results…”
    Get full text
    Journal Article
  6. 6

    Cardiopulmonary fitness in patients undergoing hematopoietic SCT: a pilot study by Wood, W A, Deal, A M, Reeve, B B, Abernethy, A P, Basch, E, Mitchell, S A, Shatten, C, Hie Kim, Y, Whitley, J, Serody, J S, Shea, T, Battaglini, C

    Published in Bone marrow transplantation (Basingstoke) (01-10-2013)
    “…Hematopoietic cell transplantation (HCT) is a life-saving treatment for patients with high-risk hematological malignancies. Prognostic measures to determine…”
    Get full text
    Journal Article
  7. 7

    Safety and tolerability of donepezil, rivastigmine and galantamine for patients with Alzheimer's disease: systematic review of the 'real-world' evidence by Lockhart, I A, Mitchell, S A, Kelly, S

    Published in Dementia and geriatric cognitive disorders (01-12-2009)
    “…The purpose of this systematic review was to compare the safety and tolerability of the cholinesterase inhibitors (ChEIs) donepezil, rivastigmine and…”
    Get more information
    Journal Article
  8. 8

    Uptake and use of recommendations for the diagnosis, severity scoring and management of chronic GVHD: an international survey of the EBMT–NCI Chronic GVHD Task Force by Duarte, R F, Greinix, H, Rabin, B, Mitchell, S A, Basak, G, Wolff, D, Madrigal, J A, Pavletic, S Z, Lee, S J

    Published in Bone marrow transplantation (Basingstoke) (01-01-2014)
    “…In 2005, the National Institutes of Health (NIH) consensus conference published a series of papers recommending methods to improve the conduct of clinical…”
    Get full text
    Journal Article
  9. 9

    Indole Adsorption to a Lipid Monolayer Studied by Optical Second Harmonic Generation by Mitchell, S. A

    Published in The journal of physical chemistry. B (06-08-2009)
    “…Adsorption of indole from an aqueous subphase to a lipid (DPPC) monolayer at the air/water interface is studied by nonresonant second harmonic generation (SHG)…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Internal ribosome entry segment-mediated translation during apoptosis: the role of IRES-trans-acting factors by Spriggs, K A, Bushell, M, Mitchell, S A, Willis, A E

    Published in Cell death and differentiation (01-06-2005)
    “…During apoptosis, there is a reduction in translation initiation caused by caspase cleavage of several of the factors required for the cap-dependent scanning…”
    Get full text
    Journal Article
  12. 12

    System dynamic modelling to assess economic viability and risk trade-offs for ecological restoration in South Africa by Crookes, D.J., Blignaut, J.N., de Wit, M.P., Esler, K.J., Le Maitre, D.C., Milton, S.J., Mitchell, S.A., Cloete, J., de Abreu, P., Fourie (nee Vlok), H., Gull, K., Marx, D., Mugido, W., Ndhlovu, T., Nowell, M., Pauw, M., Rebelo, A.

    Published in Journal of environmental management (15-05-2013)
    “…Can markets assist by providing support for ecological restoration, and if so, under what conditions? The first step in addressing this question is to develop…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Malnutrition in patients with chronic GVHD by Bassim, C W, Fassil, H, Dobbin, M, Steinberg, S M, Baird, K, Cole, K, Joe, G, Comis, L E, Mitchell, S A, Grkovic, L, Edwards, D, Mays, J W, Cowen, E W, Pulanic, D, Williams, K M, Gress, R E, Pavletic, S Z

    Published in Bone marrow transplantation (Basingstoke) (01-10-2014)
    “…Malnutrition is a known complication of chronic GVHD (cGVHD), but has not been well described in the context of organ-specific manifestations and the recent…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Validation of the National Institutes of Health chronic GVHD Oral Mucosal Score using component-specific measures by Bassim, C W, Fassil, H, Mays, J W, Edwards, D, Baird, K, Steinberg, S M, Williams, K M, Cowen, E W, Mitchell, S A, Cole, K, Taylor, T, Avila, D, Zhang, D, Pulanic, D, Grkovic, L, Fowler, D, Gress, R E, Pavletic, S Z

    Published in Bone marrow transplantation (Basingstoke) (01-01-2014)
    “…Oral chronic GVHD (cGVHD) is a common, late complication of alloSCT that is associated with significant patient morbidity. The NIH Oral Mucosal Score (NIH OMS)…”
    Get full text
    Journal Article
  17. 17

    Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity by Grkovic, L, Baird, K, Steinberg, S M, Williams, K M, Pulanic, D, Cowen, E W, Mitchell, S A, Hakim, F T, Martires, K J, Avila, D N, Taylor, T N, Salit, R B, Rowley, S D, Zhang, D, Fowler, D H, Bishop, M R, Gress, R E, Pavletic, S Z

    Published in Leukemia (01-04-2012)
    “…Chronic graft-versus-host disease (cGVHD) remains a major cause of non-relapse morbidity and mortality after allogeneic hematopoietic stem cell…”
    Get full text
    Journal Article
  18. 18

    Privileged structures: applications in drug discovery by DeSimone, R W, Currie, K S, Mitchell, S A, Darrow, J W, Pippin, D A

    “…Over the past 15 years the privileged structure concept has emerged as a fruitful approach to the discovery of novel biologically active molecules. Privileged…”
    Get more information
    Journal Article
  19. 19

    Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries by Badia, J.M., Casey, A.L., Petrosillo, N., Hudson, P.M., Mitchell, S.A., Crosby, C.

    Published in The Journal of hospital infection (01-05-2017)
    “…Surgical site infections (SSIs) are associated with increased morbidity and mortality. Furthermore, SSIs constitute a financial burden and negatively impact on…”
    Get full text
    Journal Article
  20. 20

    A blinded, placebo‐controlled study on the clinical effects of vitamin E supplementation in dogs with osteoarthritis by Gordon, Casey L., Reeves, Samantha J., Burchell, Richard K., Thomson, Craig, Gal, Arnon, Lopez‐Villalobos, Nicolas, Webster, Natalie S. L., Litster, Kimberley M., Mitchell, Richard A. S.

    Published in Journal of veterinary internal medicine (01-09-2023)
    “…Background Vitamin E has a positive effect in the management of osteoarthritis in humans, and in a previous study of dogs. It has been suggested to decrease…”
    Get full text
    Journal Article